Stay updated on Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.

Latest updates to the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page
- Check5 days agoChange DetectedThe page’s footer “Revision” label was updated from v3.5.2 to v3.5.3, reflecting a site/version update rather than a change to the study record.SummaryDifference0.0%

- Check12 days agoChange DetectedRevision updated to v3.5.2, replacing the previous v3.5.0 revision.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed in the site’s release notes.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This is a metadata/display change and does not affect study information or functionality.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded a new publication citation: Avapritinib improves cutaneous involvement in indolent systemic mastocytosis from the PIONEER study (J Am Acad Dermatol, online ahead of print).SummaryDifference0.0%

- Check77 days agoChange DetectedNew revision tag updated from v3.4.1 to v3.4.2; no other content changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.